Details
Description
The 38th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE) was held in Copenhagen, Denmark on August 24-28, 2022. More information on the conference can be found here.
A variety of Sentinel-related work was featured, including presentations, posters, and more. These materials have been made available below.
Event Materials
Symposia
- Methods and Considerations for Hypothesis-Free Signal Detection Studies Accommodating Various Types of Medications, Populations and Regions
- What Do Real World Data Validation Best Practices Look Like? Operationalizing Guidance for Real-World Studies Intended for Decision-Making
- Data Harmonization, Standardization, and Quality Assessment in Distributed Health Data Networks: Lessons from Around the World
Oral Presentations
- Arterial and Venous Thrombotic Events in Patients with COVID-19 Compared to Influenza
- Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings
- Characterizing Medication Use Among Pregnancies with COVID-19 in the Sentinel System
- Comparative Evaluation of Automated Approaches for Confounder Selection in High-Dimensional Data with Rare Outcomes
Spotlight Posters
- Racial Differences in U.S. COVID-19 Positivity, Hospitalization, and Mortality
- Use of Valganciclovir/Ganciclovir [(v)GCV] for Treatment of Congenital Cytomegalovirus (cCMV) Infection in the United States: Evidence from the Sentinel Distributed Database, 2008-2020
Posters
- Data-Driven Approaches to Improve Phenotype Sensitivity Using EHR Data
- Switching Patterns of Mixed Amphetamine Salt Products in the FDA’s Sentinel Distributed Database
- Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data
- Inverse Probability Treatment Weighting Versus Propensity Score Matching in the Sentinel System: A Test Case
- Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table
- Characterizing Pediatric Members in the Sentinel Distributed Database
- Leuprolide and Fracture Risk in Patients with Central Precocious Puberty
- Impact of Nitrosamine Contamination Recalls on Angiotensin-Receptor-Blocker (ARB) Utilization in the U.S., U.K., Canada, and Denmark
- Design Considerations for Using the Tree-based Scan Statistic in Surveillance of Maternal Outcomes Following Medication Use during Gestation